Search
for
Sort by
Research 421–450 of 1000+
- Drug News
- Non-pigmentary actions of alpha-melanocyte-stimulating hormone--lessons from the cutaneous melanocortin system.
- CUTANEOUS T-CELL LYMPHOMA
- Skin Lesions in a Daclizumab-treated Patient with Multiple Sclerosis
- Benefits of probiotics in rheumatoid arthritis patients: A systematic review and meta analysis
- Zebrafish Model of Hereditary Pigmentary Disorders
- Drug Repurposing Patent Applications April–June 2021
- Highlights from the 68th Annual Meeting of the Society of Investigative Dermatology
- Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9/2
- Abstracts of 42nd National Conference of Association of Clinical Biochemists of India (ACBICON 2015)
- CD27 and IL-35 as diagnostic biomarkers in alopecia areata: First evidence of association with pathogenic scalp bacterial infections
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway
- Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail
- Evaluation of the palatal wound healing effect of wound dressing carrying GSK-3 antagonist tideglusib on rats
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Efficacy of therapy with 311nm narrow-band UVB 311nm in the treatment of patients with alopecia areata associated with atopic dermatitis
- The evaluation of IL-4 intron 3 VNTR and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with Alopecia Areata: a case-control study
- Abstracts Pt.30
- 319 Acne, androgenetic alopecia, and atopic dermatitis in transgender patients on hormone therapy: A retrospective comparative cohort study
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Efficacy and safety of superficial cryotherapy for alopecia areata: A retrospective, comprehensive review of 353 cases over 22 years
- Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
- The Bis(1,2,3,4-tetrahydroisoquinoline) Alkaloids Cepharanthine and Berbamine Are Ligands of SK Channels
- The evaluation of IL-4 VNTR intron 3 and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with alopecia areata: a case–control study
- Atypical fibroxanthoma of the scalp following hair transplantation in a 35-year-old male
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- 3-Deoxysappanchalcone Promotes Proliferation of Human Hair Follicle Dermal Papilla Cells and Hair Growth in C57BL/6 Mice by Modulating WNT/β-Catenin and STAT Signaling
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Immunomodulators in the treatment of cutaneous lymphoma
- 34941 Case report: Hair care routine to treat the telogen effluvium associated with post–COVID-19 infection